Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Le Gouill S, Morschhauser F, Chiron D, Bouabdallah K, Cartron G, Casasnovas O, Bodet-Milin C, Ragot S, Bossard C, Nadal N, Herbaux C, Tessoulin B, Tchernonog E, Rossi C, McCulloch R, Gastinne T, Callanan MB, Rule S.
Le Gouill S, et al. Among authors: chiron d.
Blood. 2021 Feb 18;137(7):877-887. doi: 10.1182/blood.2020008727.
Blood. 2021.
PMID: 33181832
Free article.
Clinical Trial.